(Q43000093)

12 November 2017

Subacute thyroiditis during treatment with combination therapy (interferon plus ribavirin) for hepatitis C virus (English)

1 reference

12 November 2017

1 reference

1 reference

hepatitis C virus

1 reference

Paraná R

1

1 reference

12 November 2017

Cruz M

series ordinal

2

1 reference

12 November 2017

Lyra L

series ordinal

3

1 reference

12 November 2017

Cruz T

series ordinal

4

1 reference

12 November 2017

1 September 2000

1 reference

Journal of Viral Hepatitis

12 November 2017

1 reference

12 November 2017

7

1 reference

12 November 2017

5

1 reference

12 November 2017

393-395

1 reference

Clinical manifestations of hepatitis C.

12 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00247.X

Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00247.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00247.X

Extrahepatic manifestations of HCV infection: facts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00247.X

Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00247.X

10.1046/J.1365-2893.2000.00247.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference